TrialRheumatology (Oxford, England)2017

Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?

Fowzia Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.